These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 7821001)

  • 21. Drug susceptibility testing of slowly growing non-tuberculous mycobacteria using slomyco test-system.
    Litvinov V; Makarova M; Galkina K; Khachaturiants E; Krasnova M; Guntupova L; Safonova S
    PLoS One; 2018; 13(9):e0203108. PubMed ID: 30222736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In Vitro activities of isepamicin, other aminoglycosides, and capreomycin against clinical isolates of rapidly growing mycobacteria in Taiwan.
    Shen GH; Wu BD; Wu KM; Chen JH
    Antimicrob Agents Chemother; 2007 May; 51(5):1849-51. PubMed ID: 17353252
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro antibiotic susceptibility of rapidly growing nontuberculous mycobacteria isolated from patients with microbial keratitis.
    Reddy AK; Garg P; Babu KH; Gopinathan U; Sharma S
    Curr Eye Res; 2010 Mar; 35(3):225-9. PubMed ID: 20373881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro susceptibility of Mycobacterium marinum to dihydromycoplanecin A and ten other antimicrobial agents.
    Arai H; Nakajima H; Kaminaga Y
    J Dermatol; 1990 Jun; 17(6):370-4. PubMed ID: 2384640
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimicrobial susceptibility of nontuberculous mycobacteria from eye infections.
    Brown-Elliott BA; Mann LB; Hail D; Whitney C; Wallace RJ
    Cornea; 2012 Aug; 31(8):900-6. PubMed ID: 22362004
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Infections with rapidly growing mycobacteria: report of 20 cases.
    Sungkanuparph S; Sathapatayavongs B; Pracharktam R
    Int J Infect Dis; 2003 Sep; 7(3):198-205. PubMed ID: 14563223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of Etest for susceptibility testing of rapidly growing mycobacteria.
    Biehle JR; Cavalieri SJ; Saubolle MA; Getsinger LJ
    J Clin Microbiol; 1995 Jul; 33(7):1760-4. PubMed ID: 7665643
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the in vitro activity of the glycylcycline tigecycline (formerly GAR-936) with those of tetracycline, minocycline, and doxycycline against isolates of nontuberculous mycobacteria.
    Wallace RJ; Brown-Elliott BA; Crist CJ; Mann L; Wilson RW
    Antimicrob Agents Chemother; 2002 Oct; 46(10):3164-7. PubMed ID: 12234839
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nontuberculous mycobacterial ocular infections--comparing the clinical and microbiological characteristics between Mycobacterium abscessus and Mycobacterium massiliense.
    Chu HS; Chang SC; Shen EP; Hu FR
    PLoS One; 2015; 10(1):e0116236. PubMed ID: 25581038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro susceptibility patterns for rapidly growing nontuberculous mycobacteria in the United States.
    Hunkins JJ; de-Moura VC; Eddy JJ; Daley CL; Khare R
    Diagn Microbiol Infect Dis; 2023 Mar; 105(3):115882. PubMed ID: 36610383
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    Brown-Elliott BA; Rubio A; Wallace RJ
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30126964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The antimicrobial susceptibility of Mycobacterium chelonae isolated from corneal ulcer.
    Hu FR; Chang SC; Luh KT; Hung PT
    Curr Eye Res; 1997 Oct; 16(10):1056-60. PubMed ID: 9330859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Application of the Etest to the antimicrobial susceptibility testing of Mycobacterium marinum clinical isolates.
    Flynn CM; Kelley CM; Barrett MS; Jones RN
    J Clin Microbiol; 1997 Aug; 35(8):2083-6. PubMed ID: 9230386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical usefulness of amikacin and doxycycline in the treatment of infection due to Mycobacterium fortuitum and Mycobacterium chelonei.
    Dalovisio JR; Pankey GA; Wallace RJ; Jones DB
    Rev Infect Dis; 1981; 3(5):1068-74. PubMed ID: 7339806
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of different test conditions on the susceptibility of Mycobacterium fortuitum and Mycobacterium chelonae to amikacin.
    Hansen KT; Clark RB; Sanders WE
    J Antimicrob Chemother; 1994 Mar; 33(3):483-94. PubMed ID: 8040113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro synergy between clofazimine and amikacin in treatment of nontuberculous mycobacterial disease.
    van Ingen J; Totten SE; Helstrom NK; Heifets LB; Boeree MJ; Daley CL
    Antimicrob Agents Chemother; 2012 Dec; 56(12):6324-7. PubMed ID: 23027189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Postantibiotic effects of amikacin and ofloxacin on Mycobacterium fortuitum.
    Tsui SY; Yew WW; Li MS; Chan CY; Cheng AF
    Antimicrob Agents Chemother; 1993 May; 37(5):1001-3. PubMed ID: 8517688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antimicrobial susceptibility and MIC distribution of 41 drugs against clinical isolates from China and reference strains of nontuberculous mycobacteria.
    Li G; Pang H; Guo Q; Huang M; Tan Y; Li C; Wei J; Xia Y; Jiang Y; Zhao X; Liu H; Zhao LL; Liu Z; Xu D; Wan K
    Int J Antimicrob Agents; 2017 Mar; 49(3):364-374. PubMed ID: 28131606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug susceptibility of rapid and slow growing non-tuberculous mycobacteria isolated from symptomatics for pulmonary tuberculosis, Central India.
    Goswami B; Narang P; Mishra PS; Narang R; Narang U; Mendiratta DK
    Indian J Med Microbiol; 2016; 34(4):442-447. PubMed ID: 27934821
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Pang Y; Zheng H; Tan Y; Song Y; Zhao Y
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28242674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.